CN104098499A - 5-苄氧基-2-(4-苄氧基苯基)-3-甲基-1h-吲哚的制备方法 - Google Patents

5-苄氧基-2-(4-苄氧基苯基)-3-甲基-1h-吲哚的制备方法 Download PDF

Info

Publication number
CN104098499A
CN104098499A CN201310120074.4A CN201310120074A CN104098499A CN 104098499 A CN104098499 A CN 104098499A CN 201310120074 A CN201310120074 A CN 201310120074A CN 104098499 A CN104098499 A CN 104098499A
Authority
CN
China
Prior art keywords
acid
preparation
reaction
benzyloxy
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310120074.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN104098499B (zh
Inventor
陈姗
袁哲东
刘相奎
孔锐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Pharmaceutical Industry
Chia Tai Tianqing Pharmaceutical Group Co Ltd
China State Institute of Pharmaceutical Industry
Original Assignee
Shanghai Institute of Pharmaceutical Industry
China State Institute of Pharmaceutical Industry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry filed Critical Shanghai Institute of Pharmaceutical Industry
Priority to CN201310120074.4A priority Critical patent/CN104098499B/zh
Publication of CN104098499A publication Critical patent/CN104098499A/zh
Application granted granted Critical
Publication of CN104098499B publication Critical patent/CN104098499B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
CN201310120074.4A 2013-04-08 2013-04-08 5-苄氧基-2-(4-苄氧基苯基)-3-甲基-1h-吲哚的制备方法 Active CN104098499B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310120074.4A CN104098499B (zh) 2013-04-08 2013-04-08 5-苄氧基-2-(4-苄氧基苯基)-3-甲基-1h-吲哚的制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310120074.4A CN104098499B (zh) 2013-04-08 2013-04-08 5-苄氧基-2-(4-苄氧基苯基)-3-甲基-1h-吲哚的制备方法

Publications (2)

Publication Number Publication Date
CN104098499A true CN104098499A (zh) 2014-10-15
CN104098499B CN104098499B (zh) 2016-05-04

Family

ID=51667085

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310120074.4A Active CN104098499B (zh) 2013-04-08 2013-04-08 5-苄氧基-2-(4-苄氧基苯基)-3-甲基-1h-吲哚的制备方法

Country Status (1)

Country Link
CN (1) CN104098499B (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110627704A (zh) * 2018-06-21 2019-12-31 艾瑞吉瑞股份公司 巴多昔芬的制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5880137A (en) * 1996-04-19 1999-03-09 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
WO2001019794A2 (en) * 1999-09-17 2001-03-22 Baylor University Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents
CN1309637A (zh) * 1998-05-15 2001-08-22 美国家用产品公司 包含2-苯基-吲哚化合物和雌激素制剂的组合物
WO2004099139A1 (en) * 2000-09-15 2004-11-18 Baylor University Indole-containing compounds with anti-tubulin and vascular targeting activity
WO2008098527A1 (en) * 2007-02-12 2008-08-21 Zentiva A.S. Method for the preparation of 5-benzyloxy-2-(4-benzyloxphenyl)-3-methyl-1h-indole

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5880137A (en) * 1996-04-19 1999-03-09 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
CN1309637A (zh) * 1998-05-15 2001-08-22 美国家用产品公司 包含2-苯基-吲哚化合物和雌激素制剂的组合物
WO2001019794A2 (en) * 1999-09-17 2001-03-22 Baylor University Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents
WO2004099139A1 (en) * 2000-09-15 2004-11-18 Baylor University Indole-containing compounds with anti-tubulin and vascular targeting activity
WO2008098527A1 (en) * 2007-02-12 2008-08-21 Zentiva A.S. Method for the preparation of 5-benzyloxy-2-(4-benzyloxphenyl)-3-methyl-1h-indole

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHRIS P.MILLER等: "Design, Synthesis, and Preclinical Characterization of Novel, Highly Selective Indole Estrogens", 《J.MED.CHEM.》 *
GEORGE BRATULESCU: "A new and efficient one-pot synthesis of indoles", 《TETRAHEDRON LETTERS》 *
GEORGE BRATULESCU: "A new and efficient one-pot synthesis of indoles", 《TETRAHEDRON LETTERS》, vol. 49, 8 December 2007 (2007-12-08), XP022417899, DOI: doi:10.1016/j.tetlet.2007.12.015 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110627704A (zh) * 2018-06-21 2019-12-31 艾瑞吉瑞股份公司 巴多昔芬的制备方法
US10844047B2 (en) 2018-06-21 2020-11-24 Erregierre S.P.A. Process for the preparation of bazedoxifene
CN110627704B (zh) * 2018-06-21 2024-02-23 艾瑞吉瑞股份公司 巴多昔芬的制备方法

Also Published As

Publication number Publication date
CN104098499B (zh) 2016-05-04

Similar Documents

Publication Publication Date Title
US20080293943A1 (en) Process for the Preparation of 5-(4-[4-(5-Cyano-3-Indolyl)Butyl]-1-Piperazinyl)Benzofuran-2-Carboxamide
EP3390407B1 (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
KR101420892B1 (ko) 이마티닙 및 그들의 중간체 및 그 제조방법
WO2017096996A1 (zh) 卡比替尼的制备方法
CN103373989B (zh) 盐酸帕唑帕尼的中间体的制备方法
CN101024631A (zh) 替米沙坦的中间体及其制备与应用
CN101462974B (zh) 5-氨基酮戊酸盐酸盐的合成方法
CN102351778A (zh) 一种盐酸阿比朵尔的制备方法
US20210139462A1 (en) Process for the preparation of a sulfonamide structured kinase inhibitor
CN104447620B (zh) 1-[3-[3-(4-氯苯基)丙氧基]丙基]-哌啶盐酸盐的制备方法
CN104177331B (zh) 比拉斯汀的制备方法
CN109748902B (zh) 一种盐酸安罗替尼的制备方法
CN104098499A (zh) 5-苄氧基-2-(4-苄氧基苯基)-3-甲基-1h-吲哚的制备方法
CN108658805B (zh) 一种不对称偶氮苯的制备方法
CN104974105A (zh) 一种制备4-(4-氨基苯基)-3-吗啉酮的方法
CN112094290B (zh) 一种艾地骨化醇a环中间体的制备方法
CN112062767A (zh) 一种卢美哌隆的制备方法及其中间体
CN105884746A (zh) 氟马替尼的合成方法
EP3026047A1 (en) Method for producing heterocyclic compound
JP2015057381A (ja) 3,3−ジメチル−3,4−ジヒドロ−1h−キノキサリン−2−オン誘導体の製造方法およびその製造方法の中間体
CN105985348B (zh) 一种溴甲基纳曲酮的制备方法
CN103570606A (zh) 制备咔唑以及乙烯基咔唑的方法
CN101863836A (zh) 制备5,5-二苯基-2-硫代海因的方法
CN112047883B (zh) 顺苯磺酸阿曲库铵的制备方法
CN102442947A (zh) 孟鲁司特钠中间体的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
C41 Transfer of patent application or patent right or utility model
CB03 Change of inventor or designer information

Inventor after: Chen Pan

Inventor after: Yuan Zhedong

Inventor after: Liu Xiangkui

Inventor after: Kong Rui

Inventor after: Gu Hongmei

Inventor after: Wang Xiangjian

Inventor before: Chen Pan

Inventor before: Yuan Zhedong

Inventor before: Liu Xiangkui

Inventor before: Kong Rui

COR Change of bibliographic data
GR01 Patent grant
TA01 Transfer of patent application right

Effective date of registration: 20160413

Address after: 200040 Beijing West Road, Shanghai, No. 1320, No.

Applicant after: Shanghai Institute of pharmaceutical industry

Applicant after: China State Institute of Pharmaceutical Industry

Applicant after: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Address before: 200040 Beijing West Road, Shanghai, No. 1320, No.

Applicant before: Shanghai Institute of pharmaceutical industry

Applicant before: China State Institute of Pharmaceutical Industry